Stay updated on PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial

Sign up to get notified when there's something new on the PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A banner announces an NIH-wide website transition and explains that the term “Super Intelligence” may appear in place of “Artificial Intelligence” during the transition.
    Difference
    0.8%
    Check dated 2026-10-25T14:07:52.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The site’s displayed software revision was updated from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T14:22:56.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T15:08:01.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The history now includes a new revision entry for v3.7.0, superseding v3.6.6. This reflects an update to the study record's documentation in the history section.
    Difference
    0.1%
    Check dated 2026-09-20T19:28:13.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page history shows a newer revision label (v3.6.6) replacing the prior v3.6.5, signifying a system update to the study record.
    Difference
    0.1%
    Check dated 2026-08-30T17:20:24.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    A new platform revision v3.6.5 was added to the history, and the previous v3.6.4 entry was removed as part of a maintenance update.
    Difference
    0.1%
    Check dated 2026-08-09T08:46:33.000Z thumbnail image

Stay in the know with updates to PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial page.